Potassium iodide-131I (KI-131I) is a radiopharmaceutical compound used primarily in nuclear medicine for diagnostic and therapeutic purposes. It combines potassium iodide, a stable form of iodine, with iodine-131, a radioactive isotope. This product is particularly effective in the treatment of thyroid disorders, such as hyperthyroidism and thyroid cancer, as the thyroid gland naturally absorbs iodine. The radioactive iodine-131 selectively targets and destroys overactive or cancerous thyroid cells while minimizing damage to surrounding tissues. Additionally, KI-131I is used in diagnostic imaging to assess thyroid function and detect abnormalities. Its dual role in therapy and imaging makes it a valuable tool in managing thyroid-related conditions, offering precise and targeted treatment options.
Preparation Process: Potassium iodide-131I is prepared by neutron irradiation of stable potassium iodide (KI) in a nuclear reactor. Enriched potassium iodide is placed in a reactor core, where stable iodine-127 absorbs neutrons to form radioactive iodine-131. The irradiated sample is dissolved in purified water, and the solution is filtered to remove impurities. The pH is adjusted to ensure stability, and the solution is sterilized by autoclaving or filtration. The final product is dispensed into sterile vials and tested for radionuclidic purity, radiochemical purity, and sterility. The specific activity is controlled to meet pharmaceutical standards for medical use, particularly in thyroid diagnostics and therapy.
Usage Scenarios: Potassium iodide-131I (KI-131I) is a radioactive compound primarily used in nuclear medicine for diagnostic and therapeutic purposes. The radioactive isotope iodine-131 emits beta and gamma radiation, making it effective for treating thyroid disorders, such as hyperthyroidism and thyroid cancer, by selectively destroying overactive or malignant thyroid tissue. In diagnostics, it aids in thyroid imaging and function tests. Additionally, KI-131I serves as a radiotracer in research and industrial applications. Non-radioactive potassium iodide (KI) is also used as a thyroid-blocking agent in radiation emergencies to prevent radioactive iodine uptake. Its precise targeting and controlled radiation dose make it valuable in medical and scientific fields.